Á lódáil...
Neuropharmacological Actions of Metformin in Stroke
Increasing epidemiologic evidence suggests that metformin, a well-established AMPK activator and the most favorable first-line anti-diabetic drug, reduces stroke incidence and severity. However, the mechanism for this remains unclear. Moreover, previous experimental studies have reported controversi...
Na minha lista:
Foilsithe in: | Curr Neuropharmacol |
---|---|
Main Authors: | , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Bentham Science Publishers
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812800/ https://ncbi.nlm.nih.gov/pubmed/26411966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150205143555 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|